PYRIMIDINPYRAZOLYLDERIVATE

European patent · EP2872501 · In force

Register entry

Publication number
EP2872501
Application number
EP13737134
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 3, 2013
Published
May 20, 2015
Granted
Jun 1, 2016
Protection ends at the latest
Jul 2, 2033
Next annual fee due
Jul 31, 2026
IPC classes
C07D 401/14 (2006.01)
C07D 403/04 (2006.01)
A61K 31/506 (2006.01)
A61P 29/00 (2006.01)
C07D 403/14 (2006.01)
C07D 407/14 (2006.01)
C07D 413/14 (2006.01)
C07D 417/14 (2006.01)
C07D 487/08 (2006.01)
C07D 491/08 (2006.01)
C07D 491/10 (2006.01)
Priority
EP 12175660 10.07.2012
US 201261669843 P 10.07.2012
PCT application
PCT/EP2013/001950 03.07.2013
PCT publication
WO2014/008992 16.01.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2025

    Change

    Published in Swissreg on 01.08.2025

  2. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  3. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  4. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  5. Jun 1, 2016

    Granted

    Published in Swissreg on 01.06.2016

Parties

Inventor

CROSIGNANI, Stefano

F-01630 St Genis-Pouilly, FR

JORAND-LEBRUN, Catherine

F-74270 Contamine-Sarzin, FR

GERBER, Patrick

CH-1163 Etoy

MUZERELLE, Mathilde

CH-1920 Martigny

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.